Sunday, February 5, 2023

Tag: FDA advisory committee

FDA Approves Failed Alzheimer’s Drug

2
The FDA approved Biogen's failed drug aducanumab, overriding the 10-0 recommendation of its own advisory committee. Three panel members resigned in protest.

After-the-fact Pharma Payments to FDA Advisers Spark Ethical Concerns

1
From Science: "Brilinta fits a pattern of what might be called pay-later conflicts of interest, which have gone largely unnoticed—and entirely unpoliced. In examining...

Flibanserin’s ‘Effects’ Do Not Outweigh Harms, Review Finds

7
Despite concerns about the risk to benefit ratio, the FDA approved flibanserin (Addyi) to treat low female sexual desire in August. In a new...